BlackRock Advisors’s Amedisys AMED Stock Holding History

BlackRock Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$55.3M	Buy	1,296,870 +167,402	+15%	+$7.12M	0.06%	301
2016 Q3	$53.6M	Buy	1,129,468 +132,385	+13%	+$6.61M	0.06%	299
2016 Q2	$50.3M	Sell	997,083 -9,434	-0.9%	-$476K	0.05%	295
2016 Q1	$48.7M	Buy	1,006,517 +74,685	+8%	+$2.88M	0.05%	318
2015 Q4	$36.6M	Buy	931,832 +44,867	+5%	+$1.79M	0.04%	379
2015 Q3	$33.7M	Buy	886,965 +510,306	+135%	+$21.5M	0.04%	389
2015 Q2	$15M	Buy	376,659 +357,938	+1,912%	+$11.2M	0.02%	629
2015 Q1	$501K	Buy	18,721 +1,695	+10%	+$47.8K	﹤0.01%	2070
2014 Q4	$500K	Buy	17,026 +42	+0.2%	+$1.04K	﹤0.01%	2000
2014 Q3	$343K	Sell	16,984 -184	-1%	-$3.55K	﹤0.01%	2259
2014 Q2	$287K	Sell	17,168 -4,051	-19%	-$57.4K	﹤0.01%	2408
2014 Q1	$316K	Buy	21,219 +866	+4%	+$13.3K	﹤0.01%	2371
2013 Q4	$298K	Buy	20,353 +1,400	+7%	+$22.5K	﹤0.01%	2402
2013 Q3	$326K	Buy	18,953 +214	+1%	+$3.17K	﹤0.01%	2222
2013 Q2	$217K	Buy	+18,739	New	+$215K	﹤0.01%	2417

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors's AMED Position: Q4 2016 in Review

BlackRock Advisors increased its Amedisys (AMED) stake by 15% in Q4 2016, buying an estimated $7.12M and bringing the position to 1,296,870 shares worth $55.3M. The position accounts for 0.06% of the portfolio, ranked #301.

BlackRock Advisors first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.

BlackRock Advisors held 1,296,870 shares of Amedisys worth $55.3M as of Q4 2016.
BlackRock Advisors bought 167,402 Amedisys shares in Q4 2016, an estimated $7.12M.
Amedisys made up 0.06% of BlackRock Advisors's portfolio in Q4 2016, its #301 holding.
BlackRock Advisors first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.